Annemilaï Tijeras-Raballand Selected Research

Colorectal Neoplasms (Colorectal Cancer)

1/2019	Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.
4/2011	Netrin-4 delays colorectal cancer carcinomatosis by inhibiting tumor angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annemilaï Tijeras-Raballand Research Topics

Disease

20	Neoplasms (Cancer) 12/2023 - 04/2010
4	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2010
4	Carcinogenesis 03/2021 - 06/2013
3	Adenocarcinoma 12/2022 - 11/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 04/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2016 - 05/2013
2	Colonic Neoplasms (Colon Cancer) 12/2015 - 04/2011
1	Liver Neoplasms (Liver Cancer) 12/2023
1	Squamous Cell Carcinoma of Head and Neck 09/2022
1	Disease Progression 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Neoplasm Metastasis (Metastasis) 03/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2013
1	Breast Neoplasms (Breast Cancer) 12/2013
1	Prostatic Neoplasms (Prostate Cancer) 12/2013
1	Melanoma (Melanoma, Malignant) 12/2013
1	Glioblastoma (Glioblastoma Multiforme) 12/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2012
1	Primitive Neuroectodermal Tumors (PNET) 09/2012
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2012
1	Peritoneal Neoplasms 04/2011
1	Carcinoma (Carcinomatosis) 04/2011
1	Ascites 04/2011

Drug/Important Bio-Agent (IBA)

4	Everolimus FDA Link 09/2022 - 09/2012
3	Sorafenib (BAY 43-9006)FDA Link 06/2016 - 05/2013
3	Sunitinib (Sutent)FDA Link 06/2016 - 09/2012
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2013
2	Biomarkers (Surrogate Marker)IBA 05/2021 - 11/2015
2	Leucovorin (Folinic Acid)FDA Link 01/2019 - 12/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 12/2015
2	CarcinogensIBA 03/2015 - 04/2010
2	Galectin 1 (LGALS1)IBA 09/2014 - 03/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2014 - 06/2013
2	Phosphotransferases (Kinase)IBA 02/2014 - 05/2013
2	MTOR InhibitorsIBA 05/2013 - 09/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 04/2010
1	PeriostinIBA 12/2022
1	Carboplatin (JM8)FDA LinkGeneric 09/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	afliberceptIBA 01/2019
1	Axitinib (AG 013736)IBA 06/2016
1	Dihydrotachysterol (AT 10)IBA 12/2015
1	Fluorouracil (Carac)FDA LinkGeneric 12/2015
1	Adenosine Triphosphate (ATP)IBA 08/2015
1	LY-2157299IBA 08/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2015
1	Glutamine (L-Glutamine)FDA Link 07/2015
1	Antineoplastic Agents (Antineoplastics)IBA 09/2014
1	compound 0118IBA 09/2014
1	saccharide-binding proteinsIBA 09/2014
1	MitogensIBA 02/2014
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2014
1	Cysteine (L-Cysteine)FDA Link 12/2013
1	AcidsIBA 12/2013
1	Sirolimus (Rapamycin)FDA Link 05/2013
1	temsirolimus FDA Link 05/2013
1	LigandsIBA 12/2012
1	VimentinIBA 12/2012
1	Chemokine ReceptorsIBA 12/2012
1	TOR Serine-Threonine KinasesIBA 09/2012
1	Angiogenesis InhibitorsIBA 09/2012
1	neurotrophin 4IBA 04/2011
1	AntibodiesIBA 04/2010
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2010

Therapy/Procedure

12	Therapeutics 09/2022 - 04/2010
2	Drug Therapy (Chemotherapy) 09/2022 - 03/2021
1	Immunotherapy 12/2023
1	Induction Chemotherapy 09/2022
1	Adjuvant Chemotherapy 12/2015